1. ATIM-01. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; A TRANSLATIONAL TRIAL IN PROGRESS. (11th November 2019) Authors: Eibye, Simone; Hasselbalch, Benedikte; Marie Svane, Inge; Reker Hadrup, Sine; Rønn Olsen, Lars; Skjoeth-Rasmussen, Jane; Scheie, David; Østrup, Olga; Skovgaard Poulsen, Hans; Lassen, Ulrik Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPID-06. IMMUNE-RELATED PLASMA BIOMARKERS IN GLIOBLASTOMA. (11th November 2019) Authors: Bjørnbak Holst, Camilla; Jarle Christensen, Ib; Skjoeth-Rasmussen, Jane; Skovgaard Poulsen, Hans; Hamerlik, Petra; Sidenius Johansen, Julia Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT OF CONSECUTIVE NON-SELECTED GLIOBLASTOMA PATIENTS RECEIVING STANDARD THERAPY. (11th November 2019) Authors: Regner Michaelsen, Signe; Urup, Thomas; Grunnet, Kirsten; Jarle Christensen, Ib; Lassen, Ulrik; Skovgaard Poulsen, Hans Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Extracranial metastases in glioblastoma—Two case stories. Issue 2 (27th December 2018) Authors: Schou Nørøxe, Dorte; Regner Michaelsen, Signe; Broholm, Helle; Møller, Søren; Skovgaard Poulsen, Hans; Lassen, Ulrik Journal: Clinical case reports Issue: Volume 7:Issue 2(2019) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PATH-28. ANGIOTENSINOGEN PROMOTER METHYLATION TO PREDICT BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS. (11th November 2019) Authors: Urup, Thomas; Gillberg, Linn; Kaastrup, Katja; Schuang Lü, Maja; Regner Michaelsen, Signe; Larsen, Vibeke A; Jarle Christensen, Ib; Broholm, Helle; Lassen, Ulrik; Grønbæk, Kirsten; Skovgaard Poulsen, Hans Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RARE-21. CLINICAL CHARACTERISTICS OF GLIOSARCOMA AND OUTCOME FROM STANDARDIZED TREATMENT RELATIVE TO CONVENTIONAL GLIOBLASTOMA. (11th November 2019) Authors: Frandsen, Simone; Broholm, Helle; Larsen, Vibeke A; Grunnet, Kirsten; Møller, Søren; Skovgaard Poulsen, Hans; Regner Michaelsen, Signe Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET). Issue 12 (6th September 2019) Authors: Bashir, Asma; Mathilde Jacobsen, Sofie; Mølby Henriksen, Otto; Broholm, Helle; Urup, Thomas; Grunnet, Kirsten; Andrée Larsen, Vibeke; Møller, Søren; Skjøth-Rasmussen, Jane; Skovgaard Poulsen, Hans; Law, Ian Journal: Neuro-oncology Issue: Volume 21:Issue 12(2019) Page Start: 1595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Issue 1 (25th June 2021) Authors: Schou Nørøxe, Dorte; Flynn, Aidan; Westmose Yde, Christina; Østrup, Olga; Cilius Nielsen, Finn; Skjøth‐Rasmussen, Jane; Brennum, Jannick; Hamerlik, Petra; Weischenfeldt, Joachim; Skovgaard Poulsen, Hans; Lassen, Ulrik Journal: Molecular oncology Issue: Volume 16:Issue 1(2022) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗